Faculty Publications

Permanent URI for this communityhttp://192.168.24.11:4000/handle/123456789/7

Scholarly Publications by Integral Academia

Browse

Author: search.filters.author.Usama AhmadHas files: Yes

Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Regulations in Gulf Cooperation Council (GCC) Countries
    (CRC Press, 2024) Usama Ahmad; Anas Islam, Vazahat Ali
    This chapter explores the regulations governing Active Pharmaceutical Ingredient (API) drug products in the Gulf Cooperation Council (GCC) countries. It provides an overview of the GCC countries, defines APIs, and emphasizes the importance of API regulations within the region. The chapter aims to examine the regulatory framework for APIs in the GCC countries, comparing the specific regulations in Saudi Arabia, United Arab Emirates (UAE), Kuwait, Bahrain, Oman, and Qatar. To begin, the chapter delves into the general regulatory landscape surrounding APIs in the GCC countries, outlining the registration and approval processes for these crucial components of pharmaceutical products. It also highlights the post-approval requirements and monitoring mechanisms that ensure the ongoing safety and efficacy of APIs. In a comprehensive comparison, the chapter presents a detailed analysis of API regulations in each GCC country. By exploring the specific regulatory frameworks of the GCC countries, readers gain valuable insights into the similarities, differences, and unique approaches employed by each country. Additionally, the chapter addresses the challenges and issues faced in API regulations within the GCC countries. It explores compliance challenges, quality control concerns, intellectual property considerations, and the difficulties associated with harmonization. Furthermore, the chapter offers a forward-looking perspective by discussing potential future trends that may impact API regulations in the region. In conclusion, this chapter summarizes the key points discussed throughout the analysis. It underscores the significance of API regulations in the GCC countries and their impact on public health and the pharmaceutical industry. Finally, it highlights the potential for future developments in API regulations, emphasizing the need for continued attention and adaptation to meet evolving regulatory requirements and ensure the safety and quality of pharmaceutical products within the GCC countries.
  • Thumbnail Image
    Item
    Liposomes: Advances in Research and Applications
    (Nova Science Publishers, 2024) Usama Ahmad; Anas Islam
    Liposomes: Advances in Research and Applications is a comprehensive exploration of the evolving landscape of liposome science. This meticulously crafted book encompasses a spectrum of topics, ranging from the historical context and versatile properties of liposomes to their recent developments and challenges in drug delivery. The book delves into the crucial role of liposomes in cancer therapy, examining the current state and outlining future directions, with a specific focus on breast cancer, cervical cancer, and ovarian cancer therapy. Furthermore, it explores the innovative applications of liposomes in gene delivery, providing insights into methods and real-world applications. As a cohesive resource, this book serves as an indispensable guide for researchers, clinicians, and students, offering a nuanced understanding of liposomal advancements and their potential in shaping the future of drug delivery, cancer treatment, and gene therapy.
  • Thumbnail Image
    Item
    Dosage Forms - Innovation and Future Perspectives
    (IntechOpen, 2023) Usama Ahmad
    Oral solid dosage forms hold a predominant position in the drug delivery system.Tablets are the most widely used and convenient dosage form. Due to their ease of manufacturing, the minimum cost of production, easy handling and storage, and better stability, tablets are most preferred. Patients who are prescribed more than one drug are in a situation to consume multiple tablets. To minimize the counts, one or more drugs are cast into layers to form a single tablet, thus called layered tablets.Layered tablets tend to improve patient compliance and reduce the cost of production by half. Layers can be of multiple drugs or the same drug at different doses or drugs with release enhancers or drugs with fillers. Layered tablets hold a greater potential with better patient outcomes as well as stay production-friendly.
  • Thumbnail Image
    Item
    Vitamin E in Health and Disease: Interactions, Diseases and Health Aspects
    (IntechOpen, 2022) Siddiqui, Mohd Aftab; Usama Ahmad; Farogh Ahsan; Pınar Erkekoglu ed.